Home Drug Codes J Codes J3241 · TEPEZZA
Updated July 1st, 2026

TEPEZZA J Code: J3241

Injection, teprotumumab-trbw, 10 mg

Login to unlock all benchmarks

Q4 2026 Medicare Payment Limit for J3241, effective October 1, 2026: $381.627 per HCPCS billing unit, up 0.5% from $379.90. From CMS's final file.

?
Medicare Payment Limit ?
$379.90
/ HCPCS billing unit · Q3 2026
APC Payment Limit ?
$379.90
/ HCPCS billing unit · APC 9355
ASP ?
$•••.••
Login to view
WAC · AWP ?
$•••.••
Login to view
NDCs Crosswalked ?
1
View NDC crosswalk →

Drug & Product Overview

HCPCS Descriptor Injection, teprotumumab-trbw, 10 mg
HCPCS Added Date October 1, 2020
Manufacturer Amgen
Route of Administration Intravenous
Generic Status Single-Source; Branded
Dosage Type Single-Dose
Dosage Form Injection, Powder, Lyophilized, For Solution

About TEPEZZA

Tepezza is a medication aligned to the HCPCS J Code: J3241 for billing, pricing, and reimbursement purposes in the United States. It is an Ophthalmology drug administered via the intravenous route and manufactured by Amgen.

According to CMS Drug Use Information: This medication is used to treat thyroid eye disease, also known as Graves' eye disease. Teprotumumab belongs to a class of drugs known as monoclonal antibodies. It is not known exactly how it works, but it may help improve symptoms such as a feeling of irritation or grittiness in the eyes, redness or swelling of the white part of the eyeball (conjunctiva), excessive tearing or dry eyes, swelling of the eyelids, sensitivity to light, bulging of the eyes, or double vision.

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

Based on publicly available CMS files. The list of NDCs below is not exhaustive.

NDC Code Drug Manufacturer Billing Units / Pkg Package Size
75987-0130-15 Tepezza Horizon Therapeutics USA, Inc. 50 500 MG
Login for the full NDC crosswalk View pricing, complete NDC-to-HCPCS alignments, and package details.
Login →

TEPEZZA Pricing & Reimbursement

J3241 Private Payer Reimbursement
$369.23 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →
UnitedHealthcare, BlueCross BlueShield, Aetna, Cigna

Historical Graphing and Billing Calculator

per HCPCS unit
As of Q3 2026

TEPEZZA Claims Performance

Claims from Jan 2026 – Aug 2026
Claim Denial Rate 16.4%
Avg. Days to File 5.8days
Avg. Days to Pay 26.4days

Real-world claims performance from FocalPoint, OnPoint Oncology's reimbursement analytics platform, with claims data accrued at the clearing house level.

Explore J3241 claims analytics on FocalPoint →
OnPoint Oncology

TEPEZZA CPT Administration Codes

The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.

CPT Code Description
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure)
JW / JZ modifiers apply

CMS has identified Tepezza (J3241) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. Wastage billing guide →

TEPEZZA Medically Unlikely Edits (MUE)

The most billing units of J3241 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 10 mg.

Practitioner Office & Hospital Outpatient
500 units / day
= 5,000 mg per day

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

mg Enter a dose to see how many billing units it is and whether it is under the limit.

TEPEZZA Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Thyroid Eye Disease
Drug Class
Insulin-like Growth Factor-1 Receptor Inhibitor [EPC]Insulin-like Growth Factor-1 Receptor Inhibitors [MoA]

Login for BuyandBill.com Analytics

Unlock deeper insights with BuyandBill’s Comparative Report!

  • Compare ASP, WAC, and AWP across drugs.
  • Visualize Drug Price Movement Over Time
  • Tailor reports to drug class, manufacturer, or HCPCS Code.
  • Compare Biosimilar and 505(b)(2) products.

Frequently Asked Questions

Is there an available Tepezza billing and coding guide?
Billing and coding information for TEPEZZA can be found through Horizon Therapeutics. Visit Here →
Are there any available Tepezza patient assistance programs?
TEPEZZA patient assistance information can be found through Horizon Therapeutics. Visit Here →
Where can I find Tepezza prescribing information?
TEPEZZA prescribing information can be found at the link below: Visit Here →
Where can I find Tepezza side effect information?
Information regarding TEPEZZA's side effects can be found at MedlinePlus Visit Here →
Does billing TEPEZZA require JZ/JW wastage modifiers?
CMS has identified TEPEZZA(J3241) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. See CMS guidelines on use of the JZ and JW wastage modifiers below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.